{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:39:43Z","timestamp":1790033983476,"version":"4.0.1"},"reference-count":47,"publisher":"Impact Journals, LLC","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,6,7]]},"DOI":"10.18632\/oncotarget.9122","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T22:02:06Z","timestamp":1462053726000},"page":"34084-34099","source":"Crossref","is-referenced-by-count":211,"title":["Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Marco","family":"Fiorillo","sequence":"first","affiliation":[{"name":"The Breast Cancer Now Research Unit, Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"},{"name":"The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"},{"name":"The Department of Pharmacy, Health and Nutritional Sciences, The University of Calabria, Cosenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Lamb","sequence":"additional","affiliation":[{"name":"The Breast Cancer Now Research Unit, Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert B.","family":"Tanowitz","sequence":"additional","affiliation":[{"name":"Department of Medicine and Pathology, Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Mutti","sequence":"additional","affiliation":[{"name":"School of Environment and Life Sciences, University of Salford, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Krstic-Demonacos","sequence":"additional","affiliation":[{"name":"School of Environment and Life Sciences, University of Salford, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Cappello","sequence":"additional","affiliation":[{"name":"The Department of Pharmacy, Health and Nutritional Sciences, The University of Calabria, Cosenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubaldo E.","family":"Martinez-Outschoorn","sequence":"additional","affiliation":[{"name":"The Sidney Kimmel Cancer Center, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Sotgia","sequence":"additional","affiliation":[{"name":"The Breast Cancer Now Research Unit, Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"},{"name":"The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Lisanti","sequence":"additional","affiliation":[{"name":"The Breast Cancer Now Research Unit, Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"},{"name":"The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,4,30]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/bcr1982","article-title":"Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy","volume":"10","author":"Kuperwasser","year":"2008","journal-title":"Breast cancer research"},{"key":"2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.gde.2005.12.008","article-title":"Stem cells in the etiology and treatment of cancer","volume":"16","author":"Rosen","year":"2006","journal-title":"Current opinion in genetics & development"},{"key":"3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","article-title":"Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy","volume":"100","author":"Chang","year":"2008","journal-title":"Journal of the National Cancer Institute"},{"key":"4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1254\/jphs.13025FP","article-title":"Multi-drug-resistant cells enriched from chronic myeloid leukemia cells by Doxorubicin possess tumor-initiating-cell properties","volume":"122","author":"Tan","year":"2013","journal-title":"Journal of pharmacological sciences"},{"key":"5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1517\/14712590903066687","article-title":"Therapeutic implications of Cancer Initiating Cells","volume":"9","author":"Stassi","year":"2009","journal-title":"Expert opinion on biological therapy"},{"key":"6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.molcel.2014.05.015","article-title":"Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance","volume":"54","author":"Baylin","year":"2014","journal-title":"Molecular cell"},{"key":"7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update","volume":"12","author":"Ivy","year":"2015","journal-title":"Nature reviews Clinical oncology"},{"key":"8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","article-title":"Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia","volume":"458","author":"Reya","year":"2009","journal-title":"Nature"},{"key":"9","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer","volume":"29","author":"Settleman","year":"2010","journal-title":"Oncogene"},{"key":"10","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/1078-0432.CCR-09-2943","article-title":"Targeting Wnt signaling: can we safely eradicate cancer stem cells?","volume":"16","author":"Kahn","year":"2010","journal-title":"Clinical cancer research"},{"key":"11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gde.2003.11.007","article-title":"Therapeutic implications of cancer stem cells","volume":"14","author":"Clarke","year":"2004","journal-title":"Current opinion in genetics & development"},{"key":"12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2004.04.007","article-title":"Stem cell origin of cancer and differentiation therapy","volume":"51","author":"Sell","year":"2004","journal-title":"Critical reviews in oncology\/hematology"},{"key":"13","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/nature04957","article-title":"The stem-cell niche as an entity of action","volume":"441","author":"Scadden","year":"2006","journal-title":"Nature"},{"key":"14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ccr.2006.12.007","article-title":"Hit 'em where they live: targeting the cancer stem cell niche","volume":"11","author":"Wechsler-Reya","year":"2007","journal-title":"Cancer cell"},{"key":"15","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.bbadis.2010.12.009","article-title":"Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease","volume":"1812","author":"Giguere","year":"2011","journal-title":"Biochimica et biophysica acta"},{"key":"16","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1038\/onc.2012.529","article-title":"The PGC-1\/ERR signaling axis in cancer","volume":"32","author":"Giguere","year":"2013","journal-title":"Oncogene"},{"key":"17","doi-asserted-by":"publisher","first-page":"14777","DOI":"10.18632\/oncotarget.4401","article-title":"Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells","volume":"6","author":"Sotgia","year":"2015","journal-title":"Oncotarget"},{"key":"18","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.18632\/oncotarget.3174","article-title":"Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease","volume":"6","author":"Lisanti","year":"2015","journal-title":"Oncotarget"},{"key":"19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","article-title":"Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia","volume":"20","author":"Datti","year":"2011","journal-title":"Cancer cell"},{"key":"20","doi-asserted-by":"publisher","first-page":"11029","DOI":"10.18632\/oncotarget.2789","article-title":"Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validationMCT1\/2 inhibition","volume":"5","author":"Sotgia","year":"2014","journal-title":"Oncotarget"},{"key":"21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","article-title":"MYC\/PGC-1alpha Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells","volume":"22","author":"Heeschen","year":"2015","journal-title":"Cell metabolism"},{"key":"22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Lander","year":"2009","journal-title":"Cell"},{"key":"23","doi-asserted-by":"crossref","first-page":"e1930","DOI":"10.1038\/cddis.2015.263","article-title":"Early effects of the antineoplastic agent salinomycin on mitochondrial function","volume":"6","author":"Szabo","year":"2015","journal-title":"Cell death & disease"},{"key":"24","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1074\/jbc.272.7.3961","article-title":"Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite","volume":"272","author":"Vaidya","year":"1997","journal-title":"The Journal of biological chemistry"},{"key":"25","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(96)90671-6","article-title":"Atovaquone and proguanil for Plasmodium falciparum malaria","volume":"347","author":"Kremsner","year":"1996","journal-title":"Lancet"},{"key":"26","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJM199305273282103","article-title":"Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS","volume":"328","author":"Chan","year":"1993","journal-title":"The New England journal of medicine"},{"key":"27","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0006-2952(92)90213-3","article-title":"Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4\u2032-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80)","volume":"43","author":"Pudney","year":"1992","journal-title":"Biochemical pharmacology"},{"key":"28","doi-asserted-by":"crossref","first-page":"27458","DOI":"10.1074\/jbc.M502319200","article-title":"Uncovering the molecular mode of action of the antimalarial drug atovaquone using a bacterial system","volume":"280","author":"Vaidya","year":"2005","journal-title":"The Journal of biological chemistry"},{"key":"29","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1592\/phco.19.13.1050.31598","article-title":"Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study","volume":"19","author":"Masur","year":"1999","journal-title":"Pharmacotherapy"},{"key":"30","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1016\/j.bmcl.2009.07.044","article-title":"Atovaquone derivatives as potent cytotoxic and apoptosis inducing agents","volume":"19","author":"Ding","year":"2009","journal-title":"Bioorganic & medicinal chemistry letters"},{"key":"31","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2958.1999.01515.x","article-title":"Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites","volume":"33","author":"Vaidya","year":"1999","journal-title":"Molecular microbiology"},{"key":"32","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1039\/c3ce40336j","article-title":"Crystal structures and binding studies of atovaquone and its derivatives with cytochrome bc(1): a molecular basis for drug design","volume":"15","author":"Row","year":"2013","journal-title":"Crystengcomm"},{"key":"33","doi-asserted-by":"crossref","first-page":"e0136192","DOI":"10.1371\/journal.pone.0136192","article-title":"Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1\/2","volume":"10","author":"Mazoyer","year":"2015","journal-title":"PloS one"},{"key":"34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1272\/jnms.78.13","article-title":"Mitochondrial DNA alterations in colorectal cancer cell lines","volume":"78","author":"Ohta","year":"2011","journal-title":"Journal of Nippon Medical School"},{"key":"35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/3108","article-title":"Somatic mutations of the mitochondrial genome in human colorectal tumours","volume":"20","author":"Vogelstein","year":"1998","journal-title":"Nature genetics"},{"key":"36","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1158\/0008-5472.CAN-07-5532","article-title":"Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer","volume":"68","author":"Sidransky","year":"2008","journal-title":"Cancer research"},{"key":"37","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/ijc.24701","article-title":"Forced cytochrome B gene mutation expression induces mitochondrial proliferation and prevents apoptosis in human uroepithelial SV-HUC-1 cells","volume":"125","author":"Sidransky","year":"2009","journal-title":"International journal of cancer"},{"key":"38","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1159\/000366402","article-title":"CYC1 silencing sensitizes osteosarcoma cells to TRAIL-induced apoptosis","volume":"34","author":"Cheng","year":"2014","journal-title":"Cellular physiology and biochemistry"},{"key":"39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10549-007-9738-x","article-title":"Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria","volume":"110","author":"Grammatico","year":"2008","journal-title":"Breast cancer research and treatment"},{"key":"40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ygyno.2004.01.019","article-title":"Ubiquinol cytochrome c reductase (UQCRFS1) gene amplification in primary breast cancer core biopsy samples","volume":"93","author":"Young","year":"2004","journal-title":"Gynecologic oncology"},{"key":"41","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1751-1097.2012.01144.x","article-title":"Tamoxifen subcellular localization; observation of cell-specific cytotoxicity enhancement by inhibition of mitochondrial ETC complexes I and III","volume":"88","author":"Hothersall","year":"2012","journal-title":"Photochemistry and photobiology"},{"key":"42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1007695308257","article-title":"Effects of tamoxifen on the electron transport chain of isolated rat liver mitochondria","volume":"16","author":"Roussaux","year":"2000","journal-title":"Cell biology and toxicology"},{"key":"43","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.bmcl.2010.12.002","article-title":"Identification of a novel small molecule targeting UQCRB of mitochondrial complex III and its anti-angiogenic activity","volume":"21","author":"Kwon","year":"2011","journal-title":"Bioorganic & medicinal chemistry letters"},{"key":"44","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1021\/jm500863j","article-title":"Development of a novel class of mitochondrial ubiquinol-cytochrome c reductase binding protein (UQCRB) modulators as promising antiangiogenic leads","volume":"57","author":"Kwon","year":"2014","journal-title":"Journal of medicinal chemistry"},{"key":"45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10911-012-9255-3","article-title":"A detailed mammosphere assay protocol for the quantification of breast stem cell activity","volume":"17","author":"Clarke","year":"2012","journal-title":"Journal of mammary gland biology and neoplasia"},{"key":"46","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.18632\/oncotarget.3348","article-title":"Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment,\u201cdifferentiation-based nano-therapy\u201d","volume":"6","author":"Lisanti","year":"2015","journal-title":"Oncotarget"},{"key":"47","doi-asserted-by":"publisher","first-page":"10728","DOI":"10.18632\/oncotarget.3828","article-title":"Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine hedgehog-GLI signaling in breast cancer cells","volume":"6","author":"Lisanti","year":"2015","journal-title":"Oncotarget"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:13:52Z","timestamp":1589217232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,30]]},"references-count":47,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2016,6,7]]}},"alternative-id":["9122","27136895"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9122","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,30]]}}}